TFX vs WST · P/E 2083, rev $1.12B vs P/E 35, rev $1.72B
Teleflex Incorporated (TFX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the TFX and WST stock pages for the full models.
Not investment advice.